AAP
CVRS

Ardsley Advisory Partners’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Ardsley Advisory Partners’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-30,000
Closed -$41K – 196
2018
Q1 		$41K Buy
+30,000
New +$34.8K 0.01% 141

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
PVAM
Pacific View Asset Management San Francisco, California $20.8M AUM 20.08% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Ardsley Advisory Partners's CVRS Position: Q2 2018 in Review

Ardsley Advisory Partners sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q2 2018, closing a stake of 30,000 shares — an estimated $41K sold.

Ardsley Advisory Partners first reported a position in CVRS in Q1 2018 and held it in 1 quarter. The position peaked at $41K in Q1 2018. 53 funds tracked by Wall St. Rank hold CVRS as of Q2 2018.

  • Ardsley Advisory Partners reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q2 2018 after selling out during the quarter.
  • Ardsley Advisory Partners sold 30,000 CORINDUS VASCULAR ROBOTICS, INC shares in Q2 2018, an estimated $41K.
  • Ardsley Advisory Partners first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q1 2018 and held it in 1 quarter.
  • Ardsley Advisory Partners's CORINDUS VASCULAR ROBOTICS, INC position peaked at $41K in Q1 2018.
  • 53 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q2 2018.

Based on Ardsley Advisory Partners's 13F filing for Q2 2018, filed 14 Aug 2018.